Annual ROE
-48.53%
-2.11%-4.55%
December 31, 2023
Summary
- As of February 8, 2025, PACB annual return on equity is -48.53%, with the most recent change of -2.11% (-4.55%) on December 31, 2023.
- During the last 3 years, PACB annual ROE has fallen by -63.59% (-422.24%).
- PACB annual ROE is now -198.00% below its all-time high of 49.52%, reached on December 31, 2009.
Performance
PACB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-64.42%
-2.80%-4.54%
September 30, 2024
Summary
- As of February 8, 2025, PACB quarterly return on equity is -64.42%, with the most recent change of -2.80% (-4.54%) on September 30, 2024.
- Over the past year, PACB quarterly ROE has dropped by -2.80% (-4.54%).
- PACB quarterly ROE is now -112.66% below its all-time high of 508.77%, reached on June 30, 2010.
Performance
PACB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PACB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.5% | -4.5% |
| 3 y3 years | -422.2% | -542.9% |
| 5 y5 years | +52.6% | +47.5% |
PACB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.8% | at low | -113.5% | at low |
| 5 y | 5-year | -422.2% | +51.3% | -372.4% | +40.2% |
| alltime | all time | -198.0% | +82.2% | -112.7% | +81.3% |
Pacific Biosciences Of California ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -64.42%(+4.5%) |
| Jun 2024 | - | -61.62%(+43.1%) |
| Mar 2024 | - | -43.05%(-5.6%) |
| Dec 2023 | -48.53%(+4.5%) | -45.62%(-3.0%) |
| Sep 2023 | - | -47.01%(-5.6%) |
| Jun 2023 | - | -49.79%(+2.4%) |
| Mar 2023 | - | -48.63%(+5.1%) |
| Dec 2022 | -46.42%(+44.3%) | -46.25%(+13.6%) |
| Sep 2022 | - | -40.71%(+30.9%) |
| Jun 2022 | - | -31.10%(+3.1%) |
| Mar 2022 | - | -30.17%(-16.6%) |
| Dec 2021 | -32.18%(-313.7%) | -36.16%(+260.9%) |
| Sep 2021 | - | -10.02%(-72.9%) |
| Jun 2021 | - | -36.94%(+5.6%) |
| Mar 2021 | - | -34.99%(-247.9%) |
| Dec 2020 | 15.06%(-115.1%) | 23.65%(-135.0%) |
| Sep 2020 | - | -67.65%(-24.9%) |
| Jun 2020 | - | -90.02%(+15.4%) |
| Mar 2020 | - | -77.98%(-27.6%) |
| Dec 2019 | -99.58%(-2.8%) | -107.70%(-12.3%) |
| Sep 2019 | - | -122.81%(+11.3%) |
| Jun 2019 | - | -110.32%(+7.4%) |
| Mar 2019 | - | -102.75%(+4.2%) |
| Dec 2018 | -102.48%(-5.1%) | -98.57%(+8.2%) |
| Sep 2018 | - | -91.14%(+0.1%) |
| Jun 2018 | - | -91.03%(-6.5%) |
| Mar 2018 | - | -97.31%(-3.5%) |
| Dec 2017 | -107.97% | -100.81%(+4.7%) |
| Sep 2017 | - | -96.27%(+6.8%) |
| Jun 2017 | - | -90.18%(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | -87.78%(+7.1%) |
| Dec 2016 | -94.02%(+90.6%) | -81.96%(+18.5%) |
| Sep 2016 | - | -69.14%(+27.6%) |
| Jun 2016 | - | -54.17%(-2.4%) |
| Mar 2016 | - | -55.53%(-14.5%) |
| Dec 2015 | -49.34%(-53.7%) | -64.91%(-41.1%) |
| Sep 2015 | - | -110.13%(-11.8%) |
| Jun 2015 | - | -124.83%(+4.7%) |
| Mar 2015 | - | -119.17%(+12.3%) |
| Dec 2014 | -106.60%(+20.0%) | -106.13%(+12.1%) |
| Sep 2014 | - | -94.65%(-3.1%) |
| Jun 2014 | - | -97.69%(+10.5%) |
| Mar 2014 | - | -88.44%(+4.7%) |
| Dec 2013 | -88.81%(+41.4%) | -84.43%(+6.7%) |
| Sep 2013 | - | -79.15%(+9.3%) |
| Jun 2013 | - | -72.42%(+8.8%) |
| Mar 2013 | - | -66.55%(+5.0%) |
| Dec 2012 | -62.80%(+35.3%) | -63.36%(+12.2%) |
| Sep 2012 | - | -56.46%(+5.2%) |
| Jun 2012 | - | -53.68%(+10.6%) |
| Mar 2012 | - | -48.55%(+3.3%) |
| Dec 2011 | -46.42%(-83.0%) | -46.99%(-46.6%) |
| Sep 2011 | - | -87.94%(-18.8%) |
| Jun 2011 | - | -108.36%(-68.6%) |
| Mar 2011 | - | -344.76%(+13.3%) |
| Dec 2010 | -272.85%(-651.0%) | -304.19%(-345.2%) |
| Sep 2010 | - | 124.05%(-75.6%) |
| Jun 2010 | - | 508.77%(+986.9%) |
| Mar 2010 | - | 46.81%(+57.7%) |
| Dec 2009 | 49.52%(+5.7%) | 29.69% |
| Dec 2008 | 46.85% | - |
FAQ
- What is Pacific Biosciences of California annual return on equity?
- What is the all time high annual ROE for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual ROE year-on-year change?
- What is Pacific Biosciences of California quarterly return on equity?
- What is the all time high quarterly ROE for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly ROE year-on-year change?
What is Pacific Biosciences of California annual return on equity?
The current annual ROE of PACB is -48.53%
What is the all time high annual ROE for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual return on equity is 49.52%
What is Pacific Biosciences of California annual ROE year-on-year change?
Over the past year, PACB annual return on equity has changed by -2.11% (-4.55%)
What is Pacific Biosciences of California quarterly return on equity?
The current quarterly ROE of PACB is -64.42%
What is the all time high quarterly ROE for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly return on equity is 508.77%
What is Pacific Biosciences of California quarterly ROE year-on-year change?
Over the past year, PACB quarterly return on equity has changed by -2.80% (-4.54%)